Neurogene Inc
NGNE
NASDAQ
Biotechnology
$36.14
USD
+0.51 (+1.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $719.91M
Volume 115.9K
About Neurogene Inc
The company is headquartered in New York City, New York and currently employs 131 full-time employees. The company went IPO on 2014-03-07.
CEO
Dr. Rachel Mcminn
HQ
New York City, NEW YORK, US
Founded
2014
Employees
131
Key Metrics
2 metrics our research team weighs before forming a view on NGNE.
Based on Quantli research · SEC filings · as of Q2 2026
METRIC
VALUE
CHANGE
TREND (3Y)
ROE (TTM)
-51.2%
-20.3 pp
Free Cash Flow (TTM)
$-87.71M
—
Financial Snapshot
Revenue
$0
— YoY
Gross Margin
—
— YoY
Net Income
$-111.11M
-31.7%
YoY
Operating Cash Flow
$-86.82M
-18.4%
YoY
Key Statistics
Open
$35.44
Previous Close
$35.63
Day Range
$34.47 - $36.40
52 Week Range
$15.93 - $43.66
Volume
115.9K
Average Volume (10 Days)
190.0K
Dividend Yield
—
Valuation Measurement
Market Cap
$719.91M
P/E Ratio (TTM)
—
Price / Book
3.32
Financial Highlights
Return on Assets
-45.5%
Return on Equity
-51.2%
Revenue (TTM)
$0
Net Income (TTM)
$-111.11M
Diluted EPS (TTM)
-$5.03
Total Cash (MRQ)
$112.48M
Levered FCF (TTM)
$-87.71M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Similar Stocks
GYRE
Gyre Therapeutics Inc
$6.68
▲ +2.1%
MNPR
Monopar Therapeutics Inc
$113.04
▲ +2.4%
BBOT
BridgeBio Oncology Therapeutics Inc
$9.06
▼ -1.8%
CTMX
CytomX Therapeutics Inc
$3.36
▲ +0.3%
RGNX
Regenxbio Inc
$10.77
▲ +1.0%
ALLO
Allogene Therapeutics Inc
$2.05
▲ +3.5%
TECX
Tectonic Therapeutic Inc
$34.91
▲ +2.7%
IRWD
Ironwood Pharmaceuticals Inc
$4.31
▲ +5.6%
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 11
Est. EPS
Adjusted consensus estimate
-$1.37
Analyst Consensus
Based on 2 analyst ratings
Avg Target: $73.00
(+102.0% upside)
High: $81.00 · Low: $65.00
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%